ERIC BJERKHOLT
CIK 1197350 · CHIEF FINANCIAL OFFICER · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.54M
Companies
13
Total Filings
124
Lifetime Open-Market Net
-$2.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIRM | CHIEF FINANCIAL OFFICER | 42,481 | $112.23 | $4.77M | -$2.31M | 17 | 2026-07-08 |
| MGX | Director | — | $1.21 | — | $0 | 3 | 2026-06-11 |
| CERS | Director | 261,679 | $2.92 | $764.1K | $37.5K | 17 | 2026-06-11 |
| SRZNW | Director | — | $0.02 | — | $0 | 4 | 2026-05-14 |
| CalciMedica, Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 1 | 2024-08-28 |
| CALC | Director | 3,534 | $0.72 | $2.5K | $6.7K | 7 | 2024-04-22 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Chief Financial Officer | 0 | $40.39 | $0 | -$231.7K | 9 | 2023-08-11 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| COLL | Chief Financial Officer | 0 | $35.90 | $0 | $316.9K | 15 | 2020-10-14 |
| Corium International, Inc. (CORI) Delisted | Director | 0 | — | — | $89.2K | 6 | 2018-11-28 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | EVP, CFO & Corp. Secretary | 10,683 | $18.62 | $198.9K | $20.2K | 23 | 2016-12-06 |
| STEM | Director | 1,521 | $5.33 | $8.1K | $0 | 12 | 2016-01-05 |
| Viracta Therapeutics, Inc. (SNSSD) Delisted | Sr. VP, CFO & Corp. Secretary | 84,582 | — | — | $0 | 1 | 2011-03-02 |
Recent Filings · Page 2 of 13
124 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-17 | MIRM | Notice (144) | −7,287 | -$675.1K | EDGAR |
| 2026-01-30 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2026-01-28 | MIRM | Notice (144) | −1,053 | -$102.1K | EDGAR |
| 2026-01-27 | MIRM | Mixed | +1,614 | -$101.3K | EDGAR |
| 2026-01-23 | MIRM | Mixed | +1,913 | -$132.6K | EDGAR |
| 2025-09-12 | MIRM | Mixed | +8,755 | -$728.0K | EDGAR |
| 2025-08-12 | MIRM | Mixed | −5,046 | $78.3K | EDGAR |
| 2025-06-12 | MGX | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | CERS | Grant (A) | +60,000 | $0 | EDGAR |
| 2025-05-15 | SRZNW | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.